Found 23 matching trials
Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma
NAThis study is a prospective, single-arm, phase II exploratory clinical tria...
Location
The Second Qilu Hospital of Shandong University
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
PHASE2This is a prospective, multicenter, randomized, uncontrolled Phase II study...
Location
Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University
The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma
PHASE2The goal of this \[type of study:clinical trial\] is to \[learn about\] in ...
Location
School of Stomatology Wuhan University
Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma
PHASE1Dear Sir/Madam, We would like to invite you to participate in this clinical...
Location
Zhejiang Cancer Hospital
Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen
PHASE2To evaluate the efficacy and safety of adebrelimab combined with TP chemoth...
Location
The First Affiliated Hospital of Xiamen University
Neoadjuvant SNF Precision Therapy Phase III
PHASE3This study is a prospective, open-label, multicenter, randomized controlled...
Location
Fudan University Shanghai Cancer Center
Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC
PHASE2Esophageal cancer is a malignant tumor with high incidence rate and mortali...
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer
PHASE2This study aims to evaluate the efficacy and safety of neoadjuvant trastuzu...
Location
Multiple Locations
Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer
PHASE3Exploring the pathological complete response rate (pCR) of locally advanced...
Location
Fujian Medical University Union Hospital
Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma
PHASE2This study is a single arm phase II trial including 30 patients with III-IV...
Location
Multiple Locations